Biology Reference
In-Depth Information
41. Louis NA, Robinson AM, Macmanus CF, Karhausen J, Scully M, Colgan SP. (2008) Control
of IFN-{alpha}A by CD73: Implications for mucosal inflammation. J Immunol 180:4246-55.
42. Madara JL, Patapoff TW, Gillece-Castro B, Colgan SP, Parkos CA, Delp C, Mrsny RJ. (1993)
5 -adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride
secretion from T84 intestinal epithelial cell monolayers. J Clin Invest 91:2320-5.
43. Maliszewski CR, Delespesse GJ, Schoenborn MA, Armitage RJ, Fanslow WC, Nakajima
T, Baker E, Sutherland GR, Poindexter K, Birks C, Alpert A, Friend D, Gimpel SD, Gayle
RBI. (1994) The CD39 lymphoid cell activation antigen. Molecular cloning and structural
characterization. J Immunol 153:3574-83.
44. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Pinsky DJ, Sesti C, Levi R.
(2003) Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-
nucleotidase-1: implications for ischemic vascular diseases. J Pharmacol Exp Ther 305:9-16.
45. Mole DR, Schlemminger I, McNeill LA, Hewitson KS, Pugh CW, Ratcliffe PJ, Schofield CJ.
(2003) 2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase. Bioorg Med Chem Lett
13:2677-80.
46. Novak I. (2003) ATP as a signaling molecule: the exocrine focus. News Physiol Sci 18:12-17.
47. Nwogu JI, Geenen D, Bean M, Brenner MC, Huang X, Buttrick PM. (2001) Inhibition
of collagen synthesis with prolyl 4-hydroxylase inhibitor improves left ventricular function
and alters the pattern of left ventricular dilatation after myocardial infarction. Circulation
104:2216-21.
48. Oikawa M, Abe M, Kurosawa H, Hida W, Shirato K, Sato Y. (2001) Hypoxia induces tran-
scription factor ETS-1 via the activity of hypoxia-inducible factor-1. Biochem Biophys Res
Commun 289:39-43.
49. Reutershan J, Vollmer I, Stark S, Wagner R, Ngamsri KC, Eltzschig HK. (2009) Adenosine
and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking
into the lungs. Faseb J 23:473-82.
50. Robinson A, Keely S, Karhausen J, Gerich ME, Furuta GT, Colgan SP. (2008) Mucosal protec-
tion by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 134:145-55.
51. Robson SC, Wu Y, Sun X, Knosalla C, Dwyer K, Enjyoji K. (2005) Ectonucleotidases
of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin
Thromb Hemost 31:217-33.
52. Rosenberger P, Schwab JM, Mirakaj V, Masekowsky E, Mager A, Morote-Garcia JC, Unertl
K, Eltzschig HK. (2009) Hypoxia-inducible factor-dependent induction of netrin-1 dampens
inflammation caused by hypoxia. Nat Immunol 10:195-202.
53. Satchell DG, Lynch A, Bourke PM, Burnstock G. (1972) Potentiation of the effects of
exogenously applied ATP and purinergic nerve stimulation on the guinea-pig taenia coli by
dipyridamole and hexobendine. Eur J Pharmacol 19:343-50.
54. Schlemminger I, Mole DR, McNeill LA, Dhanda A, Hewitson KS, Tian YM, Ratcliffe PJ,
Pugh CW, Schofield CJ. (2003) Analogues of dealanylalahopcin are inhibitors of human HIF
prolyl hydroxylases. Bioorg Med Chem Lett 13:1451-4.
55. Semenza GL. (2000) HIF-1 and human disease: one highly involved factor. Genes Dev
14:1983-91.
56. Semenza GL. (2001) HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the
nucleus. Cell 107:1-3.
57. Semenza GL. (2009) Regulation of cancer cell metabolism by hypoxia-inducible factor 1.
Semin Cancer Biol 19:12-6.
58. Semenza GL, Agani F, Feldser D, Iyer N, Kotch L, Laughner E, Yu A. (2000) Hypoxia, HIF-1,
and the pathophysiology of common human diseases. Adv Exp Med Biol 475:123-30.
59. Sitkovsky M, Lukashev D. (2005) Regulation of immune cells by local-tissue oxygen tension:
HIF1 alpha and adenosine receptors. Nat Rev Immunol 5:712-21.
60. Smith TM, Kirley TL. (1999) Site-directed mutagenesis of a human brain ecto-apyrase: evi-
dence that the E-type ATPases are related to the actin/heat shock 70/sugar kinase superfamily.
Biochemistry 38:321-8.
Search WWH ::




Custom Search